IL-12p40 is not required for islet allograft rejection

Acta Pharmacologica Sinica

Volumn 27, Issue 8, 2006, Pages 1065-1070

  Bi, En Guang ^a   Shi, Wei ^b   Zou, Jia ^a   Hao, Zhen Hua ^b   Li, Zhen Hu ^a   Cai, Duan ^b   Zhang, Hua Qun ^b   Sun, Bing ^a,c  

^a Chinese Academy of Sciences   (China)

^b FUDAN UNIVERSITY   (China)

^c E institutes of Shanghai   (China)

Author keywords

Homologous transplantation; IL 12p40 deficient mice; Islets of Langerhans transplantation; Th1 cells; Th2 cells

Indexed keywords

GLUCOSE; INTERLEUKIN 12P40; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; KIDNEY CAPSULE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; STREPTOZOCIN DIABETES; TH1 CELL; WILD TYPE;

ANIMALS; BLOOD GLUCOSE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GRAFT REJECTION; INTERFERON TYPE II; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-4; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 33746432654     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2006.00341.x     Document Type: Article

References (38)

1. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-73.
2. Tanigawa K, Ohguni S, Kawaguchi M, Kato Y, Tanigawa K, Ohguni S, et al. Insulin release from the pancreas and fuel metabolism during late gestation in chemically diabetic rats. Endocrinol Jpn 1990; 37: 709-17.
3. Onodera K, Hancock WW, Graser E, Lehmann M, Sayegh MH, Strom TB, et al. Type 2 helper T cell-type cytokines and the development of " infectious" tolerance in rat cardiac allograft recipients. J Immunol 1997; 158: 1572-81.
4. Qin L, Chavin KD, Ding Y, Tahara H, Favaro JP, Woodward JE, et al. Retrovirus mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J Immunol 1996; 156: 2316-23.
5. Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181: 1869-74.
6. Nicolls MR, Coulombe M, Diamond AS, Beilke J, Gill RG. Interferon-gamma is not a universal requirement for islet allograft survival. Transplantation 2002; 74: 472-7.
7. Nickerson PW, Zheng XX, Steiger J, Steele AW, Steurer W, Roy-Chaudhury P, et al. Prolonged islet allograft acceptance in the absence of interleukin-4 expression. Transpl Immunol 1996; 4: 81-5.
8. Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, Culpepper JA, et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 1995; 54: 5071-9.
9. Ha SJ, Kim DJ, Baek KH, Yun YD, Sung YC. IL-23 induces stronger sustained CTL and Th1 immune responses than IL-12 in hepatitis C virus envelope protein 2 DNA immunization. J Immunol 2004; 172: 525-31.
10. Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, Ferrante J, et al. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 1996; 4: 471-81.
11. Brombacher F, Kastelein RA, Alber G. Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol 2003; 24: 207-12.
12. Gran B, Zhang GX, Yu S, Li J, Chen XH, Ventura ES, et al. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J Immunol 2002; 169: 7104-10.
13. Tarrant TK, Silver PB, Chan CC, Wiggert B, Caspi RR. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis. J Immunol 1998; 161: 122-7.
14. Nitta Y, Kawamoto S, Tashiro1 F, Aihara H, Yoshimoto T, Nariuchi H, et al. IL-12 plays a pathologic role at the inflammatory loci in the development of diabetes in NOD mice. J Autoimmun 2001; 16: 97-104.
15. Sun W, He X, Guo Z, Wang Q, Li X, Rayner J, et al. IL-12p40-over expressing immature dendritic cells induce T cell hyporesponsiveness in vitro but accelerate allograft rejection in vivo: role of NK cell activation and interferon-gamma production. Immunol Lett 2004; 94: 191-9.
16. Phillips NE, Markees TG, Mordes JP, Greiner DL, Rossini AA. Rossini blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance. J Immunol 2003; 170: 3015-23.
17. Salvalaggio PR, Deng S, Ariyan CE, Millet I, Zawalich WS, Basadonna GP, et al. Islet filtration: a simple and rapid new purification procedure that avoids ficoll and improves islet mass and function. Transplantation 2002; 74: 877-9.
18. Abdi R, Smith RN, Makhlouf L, Najafian N, Luster AD, Auchincloss H Jr, et al. The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection. Diabetes 2002; 51: 2489-95.
19. Konnai S, Usui T, Ohashi K, Onuma M. The rapid quantitative analysis of bovine cytokine genes by real-time RT-PCR. Vet Microbiol 2003; 94: 283-94.
20. Mabley JG, Hasko G, Liaudet L, Soriano F, Southan GJ, Salzman AL, et al. NFkappaB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocine-induced diabetes. J Endocrinol 2002; 173: 457-64.
21. Grajwer LA, Pildes RS, Horwitz DL, Rubenstein AH. Control of juvenile diabetes mellitus and its relationship to endogenous insulin secretion as measured by C-peptide immunoreactivity. J Pediatr 1977; 90: 42-8.
22. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13: 251-76.
23. Rabinovitch A, Suarez-Pinzon WL, Sorensen O. Interleukin-12 mRNA expression in islets correlates with beta-cell destruction in NOD mice. J Autoimmun 1996; 9: 645-51.
24. Rothe H, Burkart V, Faust A, Kolb H. Interleukin-12 gene expression is associated with development of diabetes mellitus in non-obese diabetic mice. Diabetologia 1996; 39: 119-22.
25. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L. Interleukin-12 administration induces T helper type I cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 1995; 181: 817-21.
26. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems: the differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992; 53: 1281-94.
27. Chen N, Gao Q, Field EH. Prevention of Th1 responses is critical for tolerance. Transplantation 1996; 61: 1076-83.
28. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 development pathways: application to autoimmune disease therapy. Cell 1995; 80: 707-18.
29. Piccotti JR, Chan SY, VanBuskirk AM, Eichwald EJ, Bishop DK. Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival? Transplantation 1997; 63: 619-24.
30. Zheng XX, Steele AW, Hancock WW, Stevens AC, Nickerson PW, Roy-Chaudhury P, et al. Strom. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. J Immunol 1997; 158: 4507-13.
31. Piccotti JR. IL-12 antagonism induces Th2 responses, yet exacerbates cardiac allograft rejection. J Immunol 1996; 157: 1951-7.
32. Mueller R, Krahl T, Sarvetnick N. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in NOD mice. J Exp Med 1996; 184: 1093-9.
33. Williamson E, Garside P, Bradley JA, More IA, Mowat AM. Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long-term protection from disease. J Immunol 1997; 159: 1208-15.
34. Leonard JP, Waldburger KE, Goldman SJ. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin-12. J Exp Med 1995; 181: 381-6.
35. Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W. Antibodies to interleukin-12 abrogate established experimental colitis in mice. J Exp Med 1995; 182: 1281-90.
36. Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995; 182: 1527-36.
37. Li XC, Zand MS, Li Y, Zheng XX, Strom TB. On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses. J Immunol 1998; 161; 2241-7.
38. Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 2004; 202: 96-105.